Injective (INJ) is currently trading at $2.96, reflecting a 2.50% increase over the past 24 hours. The price has fluctuated between a daily high of $2.99 and a low of $2.87, indicating a relatively tight range of $0.12 for the day.

The trading volume stands at approximately $48.81 million, representing 16.43% of its market cap, which suggests healthy liquidity in the market. Short-term moving averages are showing positive momentum, with the 55 SMA at $2.86 reflecting a 3.38% increase, while the 8 and 13 SMAs indicate steady upward pressure as well.

The one-hour Relative Strength Index (RSI) is at 57, suggesting a mildly bullish sentiment, while the seven-day RSI at 47 indicates a neutral position and a potential for further consolidation. Over the past week, INJ has experienced a decline of 2.11%, and it has dropped 8.28% over the last 14 days, signaling a bearish trend in the medium term.

Despite the recent downward pressure, the immediate price action indicates resilience, particularly with the current price above the key short-term moving averages. The all-time high remains significantly above the current price at $52.62, providing potential upside for long-term investors if market conditions improve.

In conclusion, while there are bearish trends in the medium term, the recent positive price action and strong liquidity suggest that INJ may be poised for a short-term rebound. The recommendation is to Hold, as the market shows signs of stabilization, and a clearer upward trend may emerge if momentum builds in the coming days.